AC
ACORN CAPITAL ADVISORS, LLC
NEW YORK NY · SEC CIK 0002054410
$366.46M2026Q2 reported value
20Positions
90.2%Top 10 weight · largest 21.9%
1 / 3New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
KPTI Added+$12.02M
JBIO Added+$4.44M
AURA Added+$2.37M
EUGENE THERAPEUT New+$2.20M
CGON Added+$70,979
2026Q2 top sells estimated at quarter-end value
TERNS PHARMACEUT Sold out-$92.06M
CARDIF ONCOLOGY Sold out-$2.85M
QTTB Reduced-$1.26M
X4 PHARMACEUTICA Sold out-$966,583
BCAX Reduced-$30
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | $80.39M | 21.94% | 1,131,500 | 999 | 0.1% | $70,979 | Added |
| URGN | UROGEN PHARMA LTD | $61.58M | 16.80% | 1,673,420 | 0 | 0.0% | — | Unchanged |
| TRVI | TREVI THERAPEUTICS INC | $40.00M | 10.92% | 2,144,844 | 0 | 0.0% | — | Unchanged |
| CADL | CANDEL THERAPEUTICS INC | $36.03M | 9.83% | 3,497,948 | 0 | 0.0% | — | Unchanged |
| PBYI | PUMA BIOTECHNOLOGY INC | $33.50M | 9.14% | 4,131,299 | 0 | 0.0% | — | Unchanged |
| JBIO | JADE BIOSCEINCES INC | $21.93M | 5.98% | 986,760 | 200,000 | 25.4% | $4.44M | Added |
| BCAX | BICARA THERAPEUTICS | $19.10M | 5.21% | 643,381 | -1 | -0.0% | -$30 | Reduced |
| KPTI | KARYOPHARM THERAPEUTICS INC | $14.83M | 4.05% | 1,518,113 | 1,230,287 | 427.4% | $12.02M | Added |
| OKUR | ONKURE THERAPEUTICS INC | $12.95M | 3.53% | 2,839,674 | 0 | 0.0% | — | Unchanged |
| — | HELUS PHARMA INC. | $10.18M | 2.78% | 1,540,266 | 0 | 0.0% | — | Unchanged |
| TARA | PROTARA THERAPEUTICS INC | $6.69M | 1.83% | 1,752,115 | 0 | 0.0% | — | Unchanged |
| AURA | AURA BIOSCIENCES INC | $6.60M | 1.80% | 929,077 | 333,333 | 56.0% | $2.37M | Added |
| — | LEONABIO, INC. | $5.83M | 1.59% | 634,539 | 0 | 0.0% | — | Unchanged |
| VSTM | VERASTEM INC | $5.61M | 1.53% | 1,469,153 | 0 | 0.0% | — | Unchanged |
| WHWK | WHITEHAWK THERAPEUTICS INC | $5.22M | 1.42% | 1,139,363 | 0 | 0.0% | — | Unchanged |
| QTTB | Q32 BIO INC. | $2.75M | 0.75% | 216,171 | -98,881 | -31.4% | -$1.26M | Reduced |
| — | EUGENE THERAPEUTICS | $2.20M | 0.60% | 1,271,257 | 1,271,257 | — | $2.20M | New |
| — | JASPER THERAPEUTICS | $604,027 | 0.16% | 1,438,159 | 26,667 | 1.9% | $11,200 | Added |
| — | BIOATLA INC | $447,645 | 0.12% | 108,126 | -5,298,219 | -98.0% | — | Reduced |
| — | VYNE THERAPEUTICS INC | $926 | 0.00% | 1,425 | 0 | 0.0% | — | Unchanged |
| — | TERNS PHARMACEUTICALS INC | $0 | 0.00% | 0 | -1,746,264 | -100.0% | -$92.06M | Sold out |
| — | CARDIF ONCOLOGY INC | $0 | 0.00% | 0 | -1,762,084 | -100.0% | -$2.85M | Sold out |
| — | X4 PHARMACEUTICALS INC | $0 | 0.00% | 0 | -234,039 | -100.0% | -$966,583 | Sold out |